Antibody-Induced Mitogenicity Mediated by a Chimeric CD2–c-fms Receptor

Literature Cited

• Ajcover, A., M. J. Weiss, J. F. Daley, and E. L. Reinherz. 1986. The Til surface glycoprotein is functionally linked to a calcium channel in precursor and mature T lineage cells. Proc. Natl. Acad. Sci. USA 83:2614–2618.
   PubMedGoogle Scholar
• Anderson, S. J., M. A. Gonda, C. W. Rettenmier, and C. J. Sherr. 1984. Subcellular localization of glycoproteins encoded by the viral oncogene v-fms. J. Virol. 51:730–741.
   PubMedGoogle Scholar
• Basu, A., M. Raghunath, S. Bishayee, and M. Das. 1989. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol. Cell. Biol. 9:671–677.
   PubMedGoogle Scholar
• Bierer, B. E., J. Barbosa, S. Herrmann, and S. J. Burakoff. 1988. The interaction of CD2 with its ligand, LFA-3, in human T cell proliferation. J. Immunol. 140:3358–3363.
   PubMedGoogle Scholar
• Bishayee, S., S. Majumdar, J. Khire, and M. Das. 1989. Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation. J. Biol. Chem. 264:11699–11705.
   PubMed Web of Science ®Google Scholar
• Boni-Schnetzler, M., and P. F. Pilch. 1987. Mechanism of epidermal growth factor receptor autophosphorylation and high affinity binding. Proc. Natl. Acad. Sci. USA 84:7832–7836.
   PubMedGoogle Scholar
• Chang, H.-C., P. Moingeon, P. Lopez, H. Krasnow, C. Stebbins, and E. L. Reinherz. 1989. Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production. J. Exp. Med. 169:2073–2083.
   PubMedGoogle Scholar
• Chen, W. S., C. S. Lazar, M. Poenie, R. Y. Tsien, G. N. Gui, and M. G. Rosenfield. 1987. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (London) 328:820–823.
   PubMed Web of Science ®Google Scholar
• Chou, C. K., T. J. Dull, D. S. Russell, R. Gherzi, D. Lebwohl, A. Ullrich, and O. M. Rosen. 1987. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J. Biol. Chem. 262:1842–1847.
   PubMed Web of Science ®Google Scholar
• Coussens, L., C. Van Beveren, D. Smith, E. Chen, R. L. Mitchell, C. M. Isacke, I. M. Verma, and A. Ullrich. 1986. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature (London) 320:277–280.
   PubMed Web of Science ®Google Scholar
• Downing, J. R., C. W. Rettenmier, and C. J. Sherr. 1988. Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line. Mol. Cell. Biol. 8:1795–1799.
   PubMed Web of Science ®Google Scholar
• Downing, J. R., M. F. Roussel, and C. J. Sherr. 1989. Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol. Cell. Biol. 9:2890–2896.
   PubMed Web of Science ®Google Scholar
• Dustin, M. L., M. E. Sanders, S. Shaw, and T. A. Springer. 1987. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J. Exp. Med. 165:677–692.
   PubMed Web of Science ®Google Scholar
• Ebina, Y. A., A. Araki, M. Tarra, F. Shimada, M. Mori, C. S. Craik, K. Siddle, S. B. Pierce, R. A. Roth, and W. J. Rutter. 1987. Replacement of the lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc. Natl. Acad. Sci. USA 84:704–708.
   PubMed Web of Science ®Google Scholar
• Escobedo, J. A., P. J. Barr, and L. T. Williams. 1988. Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet derived growth factor receptor. Mol. Cell. Biol. 8:5126–5131.
   PubMed Web of Science ®Google Scholar
• Furman, W. L., C. W. Rettenmier, J. H. Chen, M. F. Roussel, C. O. Quinn, and C. J. Sherr. 1986. Antibodies to distal carboxyl terminal epitopes in the v-fms-coded glycoprotein do not cross-react with the c-fms gene product. Virology 152:432–445.
   PubMed Web of Science ®Google Scholar
• Guilbert, L. J., and E. R. Stanley. 1986. The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages. J. Biol. Chem. 261:4024–4032.
   PubMed Web of Science ®Google Scholar
• Heldin, C.-H., A. Ernlund, C. Rorsman, and L. Rönnstrand. 1989. Dimerization of B-type PDGF receptors occurs after ligand binding and is closely associated with receptor kinase activation. J. Biol. Chem. 264:8905–8912.
   PubMed Web of Science ®Google Scholar
• Honegger, A. M., T. J. Dull, S. Felder, E. Van Obberghen, F. Bellot, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger. 1987. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell 51:199–209.
   PubMed Web of Science ®Google Scholar
• Honegger, A. M., D. Szapary, A. Schmidt, R. Lyall, E. Van Obberghen, T. J. Dull, A. Ullrich, and J. Schlessinger. 1987. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis. Mol. Cell. Biol. 7:4568–4571.
   PubMed Web of Science ®Google Scholar
• Howard, F. D., J. A. Ledbetter, J. Wong, C. P. Bieber, E. B. Stinson, and L. A. Herzenberg. 1981. A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E rosette formation. J. Immunol. 126:2117–2122.
   PubMed Web of Science ®Google Scholar
• Hunig, T., G. Tiefenthaler, K. H. Meyer Zum Buschenfelde, and S. C. Meuer. 1987. Alternative pathway activation of T cells by binding of CD2 to its cell surface ligand. Nature (London) 326:298–301.
   PubMed Web of Science ®Google Scholar
• Hunter, T. 1989. Protein-tyrosine phosphatases: the other side of the coin. Cell 58:1013–1016.
   PubMed Web of Science ®Google Scholar
• Kamoun, M., M. E. Kadin, P. J. Martin, J. Nettleton, and J. A. Hansen. 1981. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas. J. Immunol. 127:987–991.
   PubMed Web of Science ®Google Scholar
• Kato, J.-Y., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1989. Transduction of human colony-stimulating factor-1 receptor into interleukin-3-dependent mouse myeloid cells induces both CSF-l-dependent and factor-independent growth. Mol. Cell. Biol. 9:4069–4073.
   PubMedGoogle Scholar
• Kornfeld, S. 1982. Oligosaccharide processing during glycoprotein biosynthesis, p. 3–23. In M. Horowitz and W. Pigman (ed.), The glycoconjugates, vol. 3. Academic Press, Inc., New York.
   Google Scholar
• Lau, K.-H. W., J. R. Farley, and D. J. Baylink. 1989. Phospho-tyrosyl protein phosphatases. Biochem. J. 257:23–36.
   PubMed Web of Science ®Google Scholar
• Lee, J., T. J. Dull, I. Lax, J. Schlessinger, and A. Ullrich. 1989. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO J. 8:167–173.
   PubMed Web of Science ®Google Scholar
• Martin, P., W. C. Vass, J. T. Schüler, D. R. Lowy, and T. J. Velu. 1989. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors. Cell 59:21–32.
   PubMedGoogle Scholar
• Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway for T cell activation: a functional role for the 50 kd Til sheep erythrocyte receptor protein. Cell 36:897–906.
   PubMed Web of Science ®Google Scholar
• Moe, G. R., G. E. Bollag, and D. E. Koshland, Jr. 1989. Transmembrane signaling by a chimera of the Escherichia coli aspartate receptor and the human insulin receptor. Proc. Natl. Acad. Sci. USA 86:5683–5687.
   PubMedGoogle Scholar
• Moingeon, P., H.-C. Chang, B. P. Wallner, C. Stebbins, A. Z. Frey, and E. L. Reinherz. 1989. CD-2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature (London) 339:312–314.
   PubMedGoogle Scholar
• Moolenar, W. H., A. J. Bierman, B. C. Tilly, I. Verlaan, L. H. Defize, A. M. Honegger, A. Ullrich, and J. Schlessinger. 1988. A point mutation at the ATP-binding site of the EGF receptor abolishes signal transduction. EMBO J. 7:707–710.
   PubMedGoogle Scholar
• Ohtsuka, M., M. F. Roussel, C. J. Sherr, and J. R. Downing. 1990. Ligand-induced phosphorylation of the colony-stimulating factor 1 receptor can occur through an intermolecular reaction that triggers receptor down modulation. Mol. Cell. Biol. 10:1664–1671.
   PubMedGoogle Scholar
• Pantaleo, G., D. Olive, A. Poggi, W. J. Kozumbo, L. Moretta, and A. Moretta. 1987. Transmembrane signalling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates. Eur. J. Immunol. 17:55–60.
   PubMed Web of Science ®Google Scholar
• Rettenmier, C. W., J. H. Chen, M. F. Roussel, and C. J. Sherr. 1985. The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity. Science 228:320–322.
   PubMedGoogle Scholar
• Riedel, H., T. J. Dull, A. M. Honegger, J. Schlessinger, and A. Ullrich. 1989. Cytoplasmic domains determine signal specificity, cellular routing characteristics, and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J. 8:2943–2954.
   PubMed Web of Science ®Google Scholar
• Riedel, H., T. J. Dull, J. Schlessinger, and A. Ullrich. 1986. A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor. Nature (London) 324:68–70.
   PubMed Web of Science ®Google Scholar
• Rohrschneider, L. R., and D. Metcalf. 1989. Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells. Mol. Cell. Biol. 9:5081–5092.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., J. R. Downing, C. W. Rettenmier, and C. J. Sherr. 1988. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 55:979–988.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., T. J. Dull, C. W. Rettenmier, P. Ralph, A. Ullrich, and C. J. Sherr. 1987. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature (London) 325:549–552.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., C. W. Rettenmier, A. T. Look, and C. J. Sherr. 1984. Cell surface expression of v-fms-coded glycoproteins is required for transformation. Mol. Cell. Biol. 4:1999–2009.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., and C. J. Sherr. 1989. Mouse NIH/3T3 cells expressing human CSF-1 receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor. Proc. Natl. Acad. Sci. USA 86:7924–7927.
   PubMedGoogle Scholar
• Sayre, P. H., H.-C. Chang, R. Hussey, N. R. Brown, N. E. Richardson, G. Spagnoli, L. K. Clayton, and E. L. Reinherz. 1987. Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes. Proc. Natl. Acad. Sci. USA 84:2941–2945.
   PubMed Web of Science ®Google Scholar
• Seed, B., and A. Aruffo. 1987. Molecular cloning of CD2 antigen, the T cell erythrocyte receptor, by a rapid immunose-lection procedure. Proc. Natl. Acad. Sci. USA 84:3365–3369.
   PubMed Web of Science ®Google Scholar
• Selvaraj, P. M., M. L. Plunkett, M. Dustin, M. E. Sanders, S. Shaw, and T. A. Springer. 1987. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature (London) 326:400–403.
   PubMed Web of Science ®Google Scholar
• Sewell, W. A., M. H. Brown, J. Dunne, M. J. Owen, and M. J. Crumpton. 1986. Molecular cloning of the human T-lymphocyte surface CD2 (Til) antigen. Proc. Natl. Acad. Sci. USA 83:8718–8722.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1990. The colony-stimulating factor-1 receptor. Blood 75:1–12.
   PubMedGoogle Scholar
• Sherr, C. J., R. A. Ashmun, J. R. Downing, M. Ohtsuka, S. G. Quan, D. W. Golde, and M. F. Roussel. 1989. Inhibition of colony stimulating factor-1 activity by monoclonal antibodies to the human CSF-1 receptor. Blood 73:1786–1793.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., C. W. Rettenmier, R. Sacca, M. F. Roussel, A. T. Look, and E. R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665–676.
   PubMed Web of Science ®Google Scholar
• Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327–338.
   PubMedGoogle Scholar
• Thomas, M. L. 1989. The leukocyte common antigen family. Annu. Rev. Immunol. 7:339–369.
   PubMed Web of Science ®Google Scholar
• Wheeler, E. F., C. W. Rettenmier, A. T. Look, and C. J. Sherr. 1986. The v-fms oncogene induces factor independence and tumorigenicity in a CSF-1 dependent macrophage cell line. Nature (London) 324:377–380.
   PubMed Web of Science ®Google Scholar
• Woolford, J., A. McAuliffe, and L. R. Rohrschneider. 1988. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 55:965–977.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and J. Schlessinger. 1987. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26:1434–1442.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and J. Schlessinger. 1987. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26:1443–1451.
   PubMed Web of Science ®Google Scholar